Kite CEO Christi Shaw On How Gilead Plans To Stay On Top In Cell Therapy

 
• By Joseph Haas
  
3d illustration of T cells attacking a cancer cell
Manufacturing is key to Kite's cell therapy success, CEO Shaw says
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business